Thrombin-Induced CCN2 Expression as a Target for Anti-Fibrotic Therapy in Scleroderma

Journal of Cell Communication and Signaling - Netherlands
doi 10.1007/s12079-009-0082-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Tissue-Specific Mechanisms for CCN2/CTGF Persistence in Fibrotic Gingiva

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2007English

A Unifying Hypothesis for Scleroderma: Identifying a Target Cell for Scleroderma

Current Rheumatology Reports
Rheumatology
2010English

Paving the TRAIL to Anti-Fibrotic Therapy

Hepatology
MedicineHepatology
2016English

Mitochondrial Permeability Transition Pore as a Selective Target for Anti-Cancer Therapy

Frontiers in Oncology
Cancer ResearchOncology
2013English

The Attraction of Chemokines as a Target for Specific Anti-Inflammatory Therapy

British Journal of Pharmacology
Pharmacology
2009English

Anti-C1q Antibodies in Scleroderma

British Journal of Dermatology
DermatologyMedicine
2019English

Inhibition of Thrombin as a Novel Strategy in the Treatment of Scleroderma-Associated Interstitial Lung Disease

2012English

Regulation of Pro-Inflammatory and Pro-Fibrotic Factors by CCN2/CTGF in H9c2 Cardiomyocytes

Journal of Cell Communication and Signaling
BiochemistryCell BiologyMolecular Biology
2010English

CD248: A Therapeutic Target in Cancer and Fibrotic Diseases

Oncotarget
Oncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy